Cytovene IV is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by H2-pharma, Llc. The primary component is Ganciclovir Sodium.
| Product ID | 61269-450_21f3f765-c9da-4d2a-a0b2-f3af9a25ffc4 |
| NDC | 61269-450 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cytovene IV |
| Generic Name | Ganciclovir Sodium |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 1989-06-23 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019661 |
| Labeler Name | H2-Pharma, LLC |
| Substance Name | GANCICLOVIR SODIUM |
| Active Ingredient Strength | 500 mg/10mL |
| Pharm Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1989-06-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA019661 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1989-06-23 |
| Ingredient | Strength |
|---|---|
| GANCICLOVIR SODIUM | 500 mg/10mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0004-6940 | Cytovene | ganciclovir sodium |
| 61269-450 | Cytovene | ganciclovir sodium |
| 0143-9299 | Ganciclovir | Ganciclovir sodium |
| 14335-030 | Ganciclovir | ganciclovir sodium |
| 25021-185 | ganciclovir | ganciclovir sodium |
| 51817-171 | Ganciclovir | ganciclovir sodium |
| 63323-315 | Ganciclovir | GANCICLOVIR SODIUM |
| 70436-089 | Ganciclovir | ganciclovir sodium |
| 76233-072 | Ganciclovir | Ganciclovir Sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CYTOVENE 73632978 1444841 Live/Registered |
SYNTEX (U.S.A.) INC. 1986-11-28 |